Real-time enrollment status for this relapsed and/or refractory b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:09 PM UTC
| NCT Number | NCT04989803 |
| Recruiting Status | Recruiting |
| Condition | Relapsed and/or Refractory B-cell Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 247 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Kite, A Gilead Company |
| Last Updated on CT.gov | September 25, 2026 (3 weeks ago) |
As of October 21, 2026: Clinical trial NCT04989803 is currently recruiting participants. This phase1 study for relapsed and/or refractory b-cell lymphoma is actively seeking new participants at 21 locations across the United States. The study is sponsored by Kite, A Gilead Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04989803 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04989803 was last updated 3 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.